Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$43,750,808
+$9,272,996 QoQ
Shares Held
804,095
+0.0% QoQ
Ownership
0.325%
of shares outstanding
% of Portfolio
0.88%
of 13F equity value
Holder Rank
#54
of 739 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Derivatives in EXEL
reported options exposure · as of Dec 31, 2022CallValue
$4,571,400
CallShares
285,000
PutValue
$1,117,988
PutShares
69,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BOOTHBAY FUND MANAGEMENT, LLC holds $665,103,201 across 158 Biotechnology names. EXEL ranks #3 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
465,787 | $87,232,589 | |
| 2 | ABVX |
Abivax S.A.
|
563,367 | $75,074,286 | |
| 3 | EXEL |
Exelixis, Inc.
This page
|
804,095 | $43,750,808 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
534,163 | $31,050,895 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
692,825 | $26,812,327 | |
| 6 | CGEM |
Cullinan Therapeutics, Inc.
|
1,082,611 | $19,714,346 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
500,497 | $15,645,536 | |
| 8 | AVTX |
Avalo Therapeutics, Inc.
|
702,051 | $12,973,902 |
All Filings in EXEL
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $43,750,808 | 804,095 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $34,477,812 | 803,866 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $35,241,467 | 804,049 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $33,262,194 | 805,380 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $35,492,863 | 805,192 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $29,712,662 | 804,785 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $26,773,699 | 804,015 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $21,148,212 | 814,960 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $18,060,846 | 803,776 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $10,768,104 | 453,776 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $10,886,086 | 453,776 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $12,545,942 | 574,185 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $10,996,734 | 575,444 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $11,066,262 | 570,132 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $1,117,988 | 69,700 | Put | Other | 2023-02-14 | |
| 2022-12-31 | $4,571,400 | 285,000 | Call | Other | 2023-02-14 | |
| 2022-09-30 | $482,379 | 30,764 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $470,802 | 22,613 | Shares | Other | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||